Sirona Biochem Corp.
SRBCF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Revenue | $3 | $11 | $2 | -$32 |
| % Growth | -77% | 604.8% | 105% | – |
| Cost of Goods Sold | $0 | $2 | $2 | $3 |
| Gross Profit | $3 | $9 | -$1 | -$34 |
| % Margin | 100% | 77.8% | -52.8% | 108.1% |
| R&D Expenses | $458 | $162 | $408 | $315 |
| G&A Expenses | $199 | $340 | $332 | $164 |
| SG&A Expenses | $199 | $380 | $371 | $223 |
| Sales & Mktg Exp. | $0 | $40 | $40 | $58 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $658 | $543 | $779 | $537 |
| Operating Income | -$656 | -$380 | -$711 | -$571 |
| % Margin | -25,781.2% | -3,430.2% | -45,285.8% | 1,811.2% |
| Other Income/Exp. Net | -$228 | $3 | -$20 | -$59 |
| Pre-Tax Income | -$883 | -$531 | -$731 | -$630 |
| Tax Expense | $2 | -$113 | $1 | $1 |
| Net Income | -$885 | -$418 | -$732 | -$631 |
| % Margin | -34,808.5% | -3,774.6% | -46,588.9% | 2,000.9% |
| EPS | -0.003 | -0.002 | -0.003 | -0.003 |
| % Growth | -112.5% | 44.8% | -16% | – |
| EPS Diluted | -0.003 | -0.002 | -0.003 | -0.003 |
| Weighted Avg Shares Out | 258,673 | 254,323 | 253,605 | 253,605 |
| Weighted Avg Shares Out Dil | 258,645 | 254,323 | 253,605 | 253,605 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $0 | $0 |
| Interest Expense | $219 | $0 | $67 | $122 |
| Depreciation & Amortization | $3 | $2 | $2 | $3 |
| EBITDA | -$662 | -$419 | -$655 | -$565 |
| % Margin | -26,035.5% | -3,784.3% | -41,693% | 1,791.2% |